Published in Gene Therapy Weekly, February 15th, 2001
If the results of preliminary tests performed on animals are any indication, this therapy could potentially be used for treating humans some day.
Using genetic manipulation, researchers have introduced interleukin (IL)-12 into an adenovirus in order to target liver cancer cells. This gene therapy, when tested on three animal models, yielded good results, according to study data.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.